Cargando…
Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences
BACKGROUND: Thymidylate synthase (TS) is known to have a unique 28 bp tandemly repeated sequence in the promoter region, and the majorities of subjects have a heterozygous double repeat/triple repeat genotype in their non-cancerous tissue. Loss of heterozygosity (LOH) at the TS locus is known to occ...
Autores principales: | Kuramochi, Hidekazu, Uchida, Kazumi, Peters, Jeffery H, Shimizu, Daisuke, Vallbohmer, Daniel, Schneider, Sylke, Danenberg, Kathleen D, Danenberg, Peter V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694818/ https://www.ncbi.nlm.nih.gov/pubmed/19460136 http://dx.doi.org/10.1186/1471-2407-9-157 |
Ejemplares similares
-
Functional Polymorphism of the Thymidylate Synthase Gene in Colorectal Cancer Accompanied by Frequent Loss of Heterozygosity
por: Kawakami, Kazuyuki, et al.
Publicado: (2002) -
Thymidylate synthase, dihydropyrimidine dehydrogenase, ERCC1, and thymidine phosphorylase gene expression in primary and metastatic gastrointestinal adenocarcinoma tissue in patients treated on a phase I trial of oxaliplatin and capecitabine
por: Uchida, Kazumi, et al.
Publicado: (2008) -
Evolving management of metaplasia and dysplasia in Barrett's epithelium
por: Evans, Richard P T, et al.
Publicado: (2016) -
Interleukin-17 Expression in the Barrett's Metaplasia-Dysplasia-Adenocarcinoma Sequence
por: Bannister, J. R., et al.
Publicado: (2012) -
Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003)